Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle
- PMID: 12077289
- DOI: 10.4049/jimmunol.169.1.566
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle
Abstract
A cholera vaccine containing killed vibrios and cholera toxin B subunit (CTB) was used to compare mucosal immunization routes for induction of systemic and mucosal Ab. Four groups of women were given three monthly immunizations by the rectal immunization (R(imm)) route, nasal immunization (N(imm)) route, or vaginal immunization route during either the follicular (V-FP(imm)) or luteal (V-LP(imm)) menstrual cycle phase. N(imm) was performed with 10-fold less vaccine to determine if administration of less Ag by this route can, as in rodents, produce mucosal Ab responses comparable to those induced by higher dose R(imm) or vaginal immunization. Concentrations of Ab induced in sera and secretions were measured by ELISA. None of these routes produced durable salivary Ab responses. N(imm) induced greatest levels of CTB-specific IgG in sera. R(imm) failed to generate CTB-specific IgA in genital tract secretions. N(imm), V-FP(imm), and V-LP(imm) all produced cervical CTB-specific IgA responses comparable in magnitude and frequency. However, only V-FP(imm) induced cervical IgA2-restricted Ab to the bacterial LPS vaccine component. V-FP(imm), but not V-LP(imm), also induced CTB-specific IgA in rectal secretions. N(imm) was superior to V-FP(imm) for producing rectal CTB-specific IgA, but the greatest amounts of CTB-specific IgA and LPS-specific IgA, IgG, and IgM Ab were found in rectal secretions of R(imm) women. These data suggest that in women, N(imm) alone could induce specific Ab in serum, the genital tract, and rectum. However, induction of genital tract and rectal Ab responses of the magnitude generated by local V-FP(imm) or R(imm) will likely require administration of comparably high nasal vaccine dosages.
Similar articles
-
Influence of exogenous reproductive hormones on specific antibody production in genital secretions after vaginal vaccination with recombinant cholera toxin B subunit in humans.Clin Vaccine Immunol. 2006 Feb;13(2):202-7. doi: 10.1128/CVI.13.2.202-207.2006. Clin Vaccine Immunol. 2006. PMID: 16467326 Free PMC article.
-
Local intravaginal vaccination of the female genital tract.Scand J Immunol. 1996 Oct;44(4):408-14. doi: 10.1046/j.1365-3083.1996.d01-320.x. Scand J Immunol. 1996. PMID: 8845036 Clinical Trial.
-
Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Infect Immun. 2000 Oct;68(10):5749-55. doi: 10.1128/IAI.68.10.5749-5755.2000. Infect Immun. 2000. PMID: 10992481 Free PMC article.
-
Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.Am J Trop Med Hyg. 1994;50(5 Suppl):42-54. Am J Trop Med Hyg. 1994. PMID: 8203723 Review.
-
Immunization for protection of the reproductive tract: a review.Am J Reprod Immunol. 2002 May;47(5):265-8. doi: 10.1034/j.1600-0897.2002.01099.x. Am J Reprod Immunol. 2002. PMID: 12148540 Review.
Cited by
-
A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants.bioRxiv [Preprint]. 2022 Feb 1:2021.06.28.450181. doi: 10.1101/2021.06.28.450181. bioRxiv. 2022. Update in: J Extracell Vesicles. 2022 Mar;11(3):e12192. doi: 10.1002/jev2.12192. PMID: 35132418 Free PMC article. Updated. Preprint.
-
Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007.Vaccine. 2008 Jul 29;26(32):3969-77. doi: 10.1016/j.vaccine.2008.04.051. Epub 2008 May 8. Vaccine. 2008. PMID: 18513838 Free PMC article.
-
IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.Front Immunol. 2021 Feb 25;12:614115. doi: 10.3389/fimmu.2021.614115. eCollection 2021. Front Immunol. 2021. PMID: 33717097 Free PMC article.
-
Comparative Immunogenicity of HIV-1 gp140 Vaccine Delivered by Parenteral, and Mucosal Routes in Female Volunteers; MUCOVAC2, A Randomized Two Centre Study.PLoS One. 2016 May 9;11(5):e0152038. doi: 10.1371/journal.pone.0152038. eCollection 2016. PLoS One. 2016. PMID: 27159166 Free PMC article. Clinical Trial.
-
Mucosal Vaccine Development Based on Liposome Technology.J Immunol Res. 2016;2016:5482087. doi: 10.1155/2016/5482087. Epub 2016 Dec 29. J Immunol Res. 2016. PMID: 28127567 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous